Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this study is, in a population of patients undergoing ERCP surgery, treated preventively with NSAIDs and divided into two groups according to the absence (group 1) or presence (group 2) of intravenous lidocaine in the general anesthesia protocol. The main objective of this study is to compare the incidence of post-ERCP pancreatitis between the two groups. type of study: clinical trial participant population/health conditions: Patients with ERCP surgery
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient over 18 years of age
• Patient who has read and signed the consent form for participation in the study
• Patient candidate for ERCP with virgin papilla
Locations
Other Locations
France
Hôpital Privé des Peupliers
RECRUITING
Paris
Contact Information
Primary
Gianfranco DONATELLI, MD
donatelligianfranco@gmail.com
01 44 16 52 00
Time Frame
Start Date: 2024-01-18
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 1800
Treatments
No_intervention: General anesthesia without intravenous lidocaine administration
Experimental: General anesthesia with intravenous lidocaine administration
Related Therapeutic Areas
Sponsors
Leads: GCS Ramsay Santé pour l'Enseignement et la Recherche